Foresite Capital Management III as of Dec. 31, 2018
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 22 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 23.1 | $70M | 2.0M | 36.10 | |
| Immunomedics | 12.7 | $39M | 2.7M | 14.27 | |
| Alder Biopharmaceuticals | 9.9 | $30M | 2.9M | 10.25 | |
| Blueprint Medicines (BPMC) | 8.3 | $25M | 468k | 53.91 | |
| Arcus Biosciences Incorporated (RCUS) | 7.2 | $22M | 2.0M | 10.77 | |
| Myokardia | 5.8 | $18M | 361k | 48.86 | |
| Aimmune Therapeutics | 5.6 | $17M | 710k | 23.92 | |
| Ascendis Pharma A S (ASND) | 4.2 | $13M | 204k | 62.65 | |
| Cymabay Therapeutics | 4.1 | $13M | 1.6M | 7.87 | |
| Acceleron Pharma | 3.4 | $10M | 236k | 43.55 | |
| Replimune Group (REPL) | 2.6 | $7.8M | 780k | 10.00 | |
| Audentes Therapeutics | 2.2 | $6.7M | 315k | 21.32 | |
| Epizyme | 2.0 | $6.1M | 998k | 6.16 | |
| Tocagen | 1.8 | $5.5M | 665k | 8.21 | |
| Biohaven Pharmaceutical Holding | 1.3 | $3.9M | 106k | 36.98 | |
| Achaogen | 1.2 | $3.5M | 2.9M | 1.23 | |
| Natera (NTRA) | 1.2 | $3.5M | 252k | 13.96 | |
| Solid Biosciences | 0.9 | $2.7M | 99k | 26.80 | |
| BioDelivery Sciences International | 0.8 | $2.3M | 630k | 3.70 | |
| Wave Life Sciences (WVE) | 0.7 | $2.1M | 50k | 42.04 | |
| Verona Pharma Plc ads (VRNA) | 0.7 | $2.0M | 207k | 9.65 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $2.0M | 266k | 7.39 |
